Time
-
NEWS

Yeasen “mRNAtools” provides raw materials and professional solutions for mRNA vaccine manufacture

In order to ensure the sustainable supply of high-quality enzymes, in 2021, Yeasen invested $ 12 million to build a new mRNA vaccine raw material production base - “mRNAtools”in Wuhan, China.

2022-06-30 16:48:08

Monkeypox virus outbreak worldwide, what should we do? ——Yeasen provides enzyme raw materials for virus detection

Yeasen can provide core raw materials and overall solutions for virus detection and a complete solution for DNA pathogen detection, including sample extraction, detection premix and detection raw materials.

2022-05-24 10:14:25

IVD raw materials -- Hot-Start Taq DNA Polymerase

Considering the indicators of Taq polymerase activity, amplification efficiency, sensitivity, and antibody method hot-start polymerase, the best choice for the one-step RT-qPCR detection reagent used for SARS-Cov-2 is the antibody-based hot-start polymerase.

2022-05-19 15:20:52

COVID-19 nucleic acid detection raw material solution: fast, freeze-dried

Yeasen Biotechnology continuously provides customers with high-quality and stable nucleic acid detection raw materials to speed up and simplify COVID-19 nucleic acid testing.

2022-05-19 11:41:58

Good news! Yeasen completed the DMF filing of T7 RNA polymerase

Yeasen received a confirmation letter from the U.S FDA that the DMF data of T7 RNA polymerase submitted by the company has been received by the US FDA.

2022-05-17 17:06:21